A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
NCT ID: NCT06012435
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
703 participants
INTERVENTIONAL
2024-02-21
2028-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This clinical trial uses an experimental drug called sigvotatug vedotin, which is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial also uses a drug called docetaxel. Docetaxel is an anticancer drug that has been approved to treat non-small cell lung cancer. It is usually given to patients who previously received another anticancer treatment. In this study, one group of participants will get sigvotatug vedotin on Days 1 and 15 during each 28-day-cycle. A second group of participants will get docetaxel on Day 1 during each 21-day cycle.
This study is being done to see if sigvotatug vedotin works better than docetaxel to treat participants with NSCLC. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401
FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma
NCT00086333
Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC)
NCT01368848
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
NCT00621049
Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT00334815
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Arm
sigvotatug vedotin monotherapy
sigvotatug vedotin
Given into the vein (IV; intravenously) on Day 1 and 15 of a 28-day cycle
Control Arm
Docetaxel monotherapy
docetaxel
75 mg/m\^2 given into the vein (IV; intravenously) on Day 1 of a 21-day cycle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sigvotatug vedotin
Given into the vein (IV; intravenously) on Day 1 and 15 of a 28-day cycle
docetaxel
75 mg/m\^2 given into the vein (IV; intravenously) on Day 1 of a 21-day cycle
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants must have NSCLC with nonsquamous histology
* Tumors with squamous, or predominantly squamous histology are excluded.
* Tumors with small cell elements are excluded.
* Participants who have NSCLC with known actionable genomic alteration (AGAs) are permitted
* Participants must have received the following prior therapies and progressed during or relapsed after receiving their most recent prior therapy:
* Participants with no known AGAs must fulfill 1 of the following conditions:
* Received a platinum-based combination therapy for the treatment of metastatic or recurrent disease and a PD-(L)1 monoclonal antibody (concurrently or sequentially with platinum-based chemotherapy), unless contraindicated.
* Experienced disease progression within 6 months of the last dose of platinum-based chemotherapy in the adjuvant or neoadjuvant setting and received a PD-(L)1 monoclonal antibody at any time during the course of treatment.
* Participants with known AGAs must fulfill the following conditions:
* Must have received at least 1 relevant AGA targeted therapy and in the opinion of the investigator, additional AGA targeted therapy is not in the best interest of the participant.
* Received a platinum-based combination therapy for the treatment of metastatic or recurrent disease, or experienced disease progression within 6 months of the last dose of platinum-based chemotherapy in the adjuvant or neoadjuvant setting
* May have received up to 1 PD-(L)1 monoclonal antibody (concurrently or sequentially with platinum-based chemotherapy).
* Measurable disease based on RECIST v1.1
* Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, with adequate baseline hematologic, hepatic, and renal function and measurable disease according to RECIST v1.1
Exclusion Criteria
* Known allergies/hypersensitivity/intolerance to or contraindication of taxanes, docetaxel, or any excipient contained in the drug formulation of sigvotatug vedotin
* History of another malignancy within 3 years before Cycle 1 Day 1, or any evidence of residual disease from a previously diagnosed malignancy. Exceptions are malignancies with a negligible risk of metastasis or death
* Participants with any of the following respiratory conditions:
* Evidence of noninfectious interstitial lung disease (ILD) or pneumonitis that:
* Was previous diagnosed and required systemic steroids, or
* Is currently diagnosed and managed, or
* Is suspected on radiologic imaging at screening
* Known diffusing capacity of the lung for carbon monoxide (DLCO) \< 50%
* Any Grade greater than or equal to (≥) 3 pulmonary disease unrelated to underlying malignancy
* Pre-existing peripheral neuropathy Grade greater than or equal to (≥) 2
* Uncontrolled diabetes mellitus
* Prior therapy:
* Prior treatment with antimicrotubule agents (taxanes, vinca alkaloids, or MMAEs) in the locally advanced, unresectable/refractory, or metastatic setting
* Prior antimicrotubule agent exposure in curative settings (including adjuvant, neoadjuvant, or chemoradiotherapy) is permissible.
* Received more than 1 prior line of cytotoxic chemotherapy in the locally advanced, unresectable/refractory, or metastatic setting
* Prior cytotoxic chemotherapy in curative settings is permissible
* At least 14 days must have elapsed from the last dose of radiotherapy until Cycle 1 Day 1.
* Prior radiation therapy to the lung parenchyma that is \>30 Gray (Gy) within 6 months of Cycle 1 Day 1.
* Any systemic anticancer therapy (standard or experimental) within 21 days prior to Cycle 1 Day 1.
* Active central nervous system (CNS) lesions, including leptomeningeal metastasis, are excluded. Participants with definitively treated brain metastases are eligible in they meet the following criteria:
* Have been clinically stable for at least 4 weeks prior to treatment initiation and baseline scans show no evidence of new or enlarged metastasis
* On a stable dose of less than or equal to (≤) 10mg/day of prednisone or equivalent for a least 2 weeks (if requiring steroid treatment)
* Treatment with corticosteroids greater than (\>) 1 month prior to Screening visit
* No evidence of clinical and radiographic disease progression in the CNS for ≥ 21 days after definitive radiotherapy and/or surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seagen, a wholly owned subsidiary of Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alaska Oncology and Hematology, LLC
Anchorage, Alaska, United States
Providence Medical Foundation
Fullerton, California, United States
Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center
Fullerton, California, United States
Providence St. Jude Medical Center
Fullerton, California, United States
Cancer and Blood Specialty Clinic
Los Alamitos, California, United States
Cancer Blood and Specialty Clinic
Los Alamitos, California, United States
TRIO US Central Administration
Los Angeles, California, United States
Drug Management Only: UCLA West Medical Pharmacy Attn: Steven L. Wong, Pharma.D.
Los Angeles, California, United States
Drug Management Only: UCLA West Medical Pharmacy, Attn: Steven L Wong, Pharm.D.
Los Angeles, California, United States
UCSF Medical Center - Mission Bay
San Francisco, California, United States
Sansum Clinic
Santa Barbara, California, United States
Sansum Clinic
Solvang, California, United States
Rocky Mountain Cancer Centers LLP
Aurora, Colorado, United States
Rocky Mountain Cancer Centers LLP
Boulder, Colorado, United States
Rocky Mountain Cancer Centers LLP
Colorado Springs, Colorado, United States
Rocky Mountain Cancer Centers LLP
Colorado Springs, Colorado, United States
Rocky Mountain Cancer Centers LLP
Denver, Colorado, United States
Rocky Mountain Cancer Centers LLP
Denver, Colorado, United States
Rocky Mountain Cancer Centers LLP
Lakewood, Colorado, United States
Rocky Mountain Cancer Centers LLP
Littleton, Colorado, United States
Rocky Mountain Cancer Centers LLP
Lone Tree, Colorado, United States
Rocky Mountain Cancer Centers LLP
Longmont, Colorado, United States
Rocky Mountain Cancer Centers LLP
Pueblo, Colorado, United States
Rocky Mountain Cancer Centers LLP
Thornton, Colorado, United States
Cancer Specialists of North Florida
Fleming Island, Florida, United States
Cancer Specialists of North Florida
Jacksonville, Florida, United States
Cancer Specialists of North Florida
Jacksonville, Florida, United States
Cancer Specialists of North Florida
Jacksonville, Florida, United States
Cancer Specialists of North Florida
Jacksonville, Florida, United States
Cancer Care Centers of Brevard, Inc.
Melbourne, Florida, United States
Baptist Hospital of Miami
Miami, Florida, United States
Miami Cancer Institute at Baptist Health, Inc.
Miami, Florida, United States
Cancer Specialists of North Florida
Neptune Beach, Florida, United States
Cancer Care Centers of Brevard, Inc.
Palm Bay, Florida, United States
Cancer Care Centers of Brevard, Inc.
Rockledge, Florida, United States
Cancer Specialists of North Florida
Saint Augustine, Florida, United States
Illinois Cancer Specialists
Arlington Heights, Illinois, United States
Illinois Cancer Specialists
Niles, Illinois, United States
Maryland Oncology Hematology P.A.
Annapolis, Maryland, United States
Maryland Oncology Hematology P.A.
Bethesda, Maryland, United States
Maryland Oncology Hematology P.A.
Brandywine, Maryland, United States
Maryland Oncology Hematology P.A.
Columbia, Maryland, United States
Maryland Oncology Hematology P.A.
Germantown, Maryland, United States
Maryland Oncology Hematology P.A.
Largo, Maryland, United States
Maryland Oncology Hematology P.A.
Rockville, Maryland, United States
Maryland Oncology Hematology P.A.
Silver Spring, Maryland, United States
Boston Medical Center
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Southcoast Centers for Cancer Care
Fairhaven, Massachusetts, United States
Southcoast Centers for Cancer Care
Fall River, Massachusetts, United States
Allina Health Cancer Institute - Mercy Hospital
Coon Rapids, Minnesota, United States
Allina Health Cancer Institute - Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
Allina Health Cancer Institute - United Hospital
Saint Paul, Minnesota, United States
Hattiesburg Clinic Hematology/Oncology.
Hattiesburg, Mississippi, United States
St Luke's Cancer Institute
Kansas City, Missouri, United States
Nebraska Medicine
Bellevue, Nebraska, United States
Nebraska Medicine
Omaha, Nebraska, United States
Nebraska Medicine
Omaha, Nebraska, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Summit Medical Group
Berkeley Heights, New Jersey, United States
Summit Medical Group
Clifton, New Jersey, United States
Summit Medical Group
Florham Park, New Jersey, United States
NYU Langone Hospital - Long Island
Mineola, New York, United States
Perlmutter Cancer Center at NYU Langone Hospital - Long Island
Mineola, New York, United States
Laura & Isaac Perlmutter Cancer Center - NYU ACC
New York, New York, United States
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, United States
NYU Langone Medical Center (Tisch Hospital)
New York, New York, United States
University Hospitals Seidman Cancer Center at UH Avon Health Center
Avon, Ohio, United States
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, Ohio, United States
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, Ohio, United States
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, Ohio, United States
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy
Cleveland, Ohio, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Cleveland Clinic Cancer Center/Fairview Hospital Moll Cancer Pavilion
Cleveland, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Oncology Hematology Care Clinical Trials, LLC
Fairfield, Ohio, United States
Taylor Cancer Research Center
Maumee, Ohio, United States
Cleveland Clinic Cancer Center/Hillcrest Hospital Cancer Center Pharmacy
Mayfield Heights, Ohio, United States
University Hospitals Seidman Cancer Center at UH Mentor Health Center
Mentor, Ohio, United States
UH Minoff Health Center at Chagrin Highlands
Orange, Ohio, United States
Oregon Health and Science University - CHO Beaverton
Beaverton, Oregon, United States
Oncology Associates of Oregon, P.C.
Eugene, Oregon, United States
Oregon Health and Science University - CHO Gresham
Gresham, Oregon, United States
Oregon Health and Science University - CHO Northwest
Portland, Oregon, United States
Northwest Cancer Specialists, P.C.
Portland, Oregon, United States
Oregon Health and Science University - CHO East Portland
Portland, Oregon, United States
Northwest Cancer Specialists, P.C.
Portland, Oregon, United States
Oregon Health and Science University (CHH1)
Portland, Oregon, United States
Oregon Health and Science University (CHH2)
Portland, Oregon, United States
Oregon Health and Science University
Portland, Oregon, United States
Northwest Cancer Specialists, P.C.
Tigard, Oregon, United States
Oregon Health and Science University - CHO Tualatin
Tualatin, Oregon, United States
Alliance Cancer Specialists, PC
Bensalem, Pennsylvania, United States
Alliance Cancer Specialists, PC
Doylestown, Pennsylvania, United States
Alliance Cancer Specialists, PC
Horsham, Pennsylvania, United States
Alliance Cancer Specialists, PC
Langhorne, Pennsylvania, United States
Alliance Cancer Specialists, PC
Media, Pennsylvania, United States
Alliance Cancer Specialists, PC
Sellersville, Pennsylvania, United States
Alliance Cancer Specialists, PC
Wynnewood, Pennsylvania, United States
Texas Oncology - West Texas
Abilene, Texas, United States
Texas Oncology - West Texas
Amarillo, Texas, United States
Texas Oncology - Central South
Austin, Texas, United States
Texas Oncology - Central South
Austin, Texas, United States
Texas Oncology - Central South
Austin, Texas, United States
University of Texas Southwestern Medical Center - Simmons Cancer Center
Dallas, Texas, United States
UT Southwestern Medical Center - Redbird
Dallas, Texas, United States
Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital
Dallas, Texas, United States
University of Texas Southwestern Medical Center - William P. Clements, Jr., University Hospital
Dallas, Texas, United States
University Of Texas Southwestern Medical Center
Dallas, Texas, United States
Texas Oncology - West Texas
El Paso, Texas, United States
Texas Oncology - West Texas
El Paso, Texas, United States
Texas Oncology - West Texas
El Paso, Texas, United States
UT Southwestern - Simmons Cancer Center - Fort Worth
Fort Worth, Texas, United States
US Oncology Investigational Product Center (IPC)
Irving, Texas, United States
US Oncology Investigational Products Center (IPC)
Irving, Texas, United States
Texas Oncology - West Texas
Midland, Texas, United States
Texas Oncology - West Texas
Odessa, Texas, United States
UT Southwestern - Simmons Cancer Center - Richardson/Plano
Richardson, Texas, United States
Texas Oncology - Central South
Waco, Texas, United States
Texas Oncology - West Texas
Wichita Falls, Texas, United States
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Blacksburg, Virginia, United States
Oncology & Hematology Associates of Southwest Virginia, INC.
Low Moor, Virginia, United States
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Roanoke, Virginia, United States
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Salem, Virginia, United States
Oncology & Hematology Associates of Southwest Virginia, INC.
Wytheville, Virginia, United States
Northwest Medical Specialties, PLLC
Bonney Lake, Washington, United States
Northwest Medical Specialties, PLLC
Federal Way, Washington, United States
Northwest Medical Specialties, PLLC
Gig Harbor, Washington, United States
American Oncology Network Vista Oncology Division-West office
Olympia, Washington, United States
American Oncology Network Vista Oncology Division
Olympia, Washington, United States
Northwest Medical Specialties, PLLC
Puyallup, Washington, United States
Northwest Medical Specialties, PLLC
Tacoma, Washington, United States
Northwest Cancer Specialists, P.C.
Vancouver, Washington, United States
Froedtert Hospital/Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Instituto de Investigaciones Clinicas de Mar del Plata
Mar del Plata, Buenos Aires, Argentina
CEMAIC - Centro Medico Privado
Córdoba, Cundinamarca, Argentina
Sanatorio Parque
Rosario, Santa Fe Province, Argentina
Hospital Provincial del Centenario
Rosario, Santa Fe Province, Argentina
Sanatorio Allende Cerro
Córdoba, , Argentina
Centro Oncologico de Excelencia
San Juan, , Argentina
Border Medical Oncology Research Unit
Albury, New South Wales, Australia
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Peninsula Health, Frankston Hospital
Franskton, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
St John of God Hospital Murdoch
Murdoch, Western Australia, Australia
AKH - Medizinische Universitat Wien
Vienna, , Austria
Riedl-Prayer-Drahanowsky-Barton Radiologiegruppenpraxis OG (RPDB)- Imagingpraterstern
Vienna, , Austria
Algemeen Ziekenhuis klina
Brasschaat, , Belgium
Universitair Ziekenhuis Antwerpen
Edegem, , Belgium
Universitair Ziekenhuis Gent
Ghent, , Belgium
Jessa Ziekenhuis VZW
Hasselt, , Belgium
CHU de Liege
Liège, , Belgium
Oncosite - Centro de Pesquisa Clinica e Oncologia
Ijuí, Rio Grande do Sul, Brazil
União Brasileira de Educação e Assitência (UBEA), mantenedora do Hospital São Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Cancer de Barretos - Fundacao Pio XII
Barretos, São Paulo, Brazil
Fundação Doutor Amaral Carvalho.
Jaú, São Paulo, Brazil
CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia
Santo André, São Paulo, Brazil
Centro Paulista de Oncologia S A
São Paulo, São Paulo, Brazil
Hospital Mãe de Deus
Porto Alegre, , Brazil
Nucleo de Oncologia da Bahia - Oncoclinicas
Salvador, , Brazil
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
Cross Cancer Institute
Edmonton, Alberta, Canada
William Osler Health System - Brampton Civic Hospital.
Brampton, Ontario, Canada
William Osler Health System - Peel Memorial Hospital
Brampton, Ontario, Canada
William Osler Health System - Etobicoke General Hospital
Etobicoke, Ontario, Canada
Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Sunnybrook Research Institute
Toronto, Ontario, Canada
CISSS de la Monteregie-Centre
Greenfield Park, Quebec, Canada
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada
The Research Institute of the McGill University Health Centre
Montreal, Quebec, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Centro de Investigacion Clinica Bradford Hill
Recoleta, Santiago Metropolitan, Chile
CeCim Biocinetic
Santiago, Santiago Metropolitan, Chile
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Fujian provincial Cancer Hospital
Fuzhou, Fujian, China
The First People's Hospital of Foshan
Foshan, Guangdong, China
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Jiangmen Central Hospital
Jiangmen, Guangdong, China
Guangxi Medical University Affiliated Tumor Hospital
Nanning, Guangxi, China
Guangxi Medical University Affiliated Tumor Hospital
Nanning, Guangxi, China
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang, Henan, China
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang, Henan, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Hunan Cancer Hospital
Changsha, Hunan, China
Inner Mongolia Autonomous Region People's Hospital
Hothot, Inner Mongolia, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Jilin Cancer Hospital
Changchun, Jilin, China
Shandong Cancer Hospital
Jinan, Shandong, China
LinYi Cancer Hospital
Linyi, Shandong, China
First Affiliated Hospital of Xi 'an Jiaotong University
Xi'an, Shannxi, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Sichuan Province Cancer Hospital
Chengdu, Sichuan, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Tianjin Cancer Hospital
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
Beijing Cancer Hospital
Beijing, , China
Beijing Chest Hospital, Capital Medical University
Beijing, , China
Chongqing University Cancer Hospital
Chongqing, , China
Fudan University Shanghai Cancer Center
Shanghai, , China
Vseobecna Fakultni Nemocnice v Praze
Prague, Praha 2, Czechia
Nemocnice AGEL Ostrava Vitkovice a.s.,
Ostrava, , Czechia
CHU de Besancon - Hopital Jean Minjoz
Besançon, , France
Centre Hospitalier de Cholet
Cholet, , France
Centre Hospitalier Intercommunal Creteil - CHI Creteil
Créteil, , France
CHRU de Lille
Lille, , France
Hopital Nord - Batiment Mistral
Marseille, , France
Centre de Cancerologie du Grand Montpellier
Montpellier, , France
Service UPCC, R-1, Clinique Clementville
Montpellier, , France
Hopital Cochin, APHP Centre Universite de Paris
Paris, , France
Hopital Bichat-Claude Bernard - APHP
Paris, , France
CHU de Bordeaux, Hopital du Haut-Leveque, Centre Francois Magendie
Pessac, , France
CH de Cornouaille
Quimper, , France
Centre Hospitalier Universitaire de Rennes, Hopital Pontchaillou
Rennes, , France
Institut de Cancerologie Strasbourg Europe
Strasbourg, , France
Hopital Sainte Musse
Toulon, , France
CHU Toulouse - Hopital Larrey
Toulouse, , France
IGR Gustave Roussy
Villejuif, , France
Johanniter Krankenhaus Bonn
Bonn, , Germany
Klinikum Esslingen GmbH
Esslingen am Neckar, , Germany
Universitatsklinkik Frankfurt
Frankfurt, , Germany
Asklepios Klinik Gauting GmbH
Gauting, , Germany
LungenClinic Grosshansdorf
Großhansdorf, , Germany
Krankenhaus Martha-Maria Halle Dölau gGmbH Klinik für Innere Medizin II
Halle, , Germany
Thoraxklinik Heidelberg gGmbH
Heidelberg, , Germany
General Hospital of Athens Alexandra
Athens, Attikí, Greece
University Hospital of Larissa
Larissa, Thessaly, Greece
Bioiatriki Private Medical S.A.
Athens, , Greece
Henry Dunant Hospital Center
Athens, , Greece
Metropolitan Hospital
N.Faliro, , Greece
General University Hospital of Patras
Pátrai, , Greece
Interbalkan Medical Center
Pilea Thessaloniki, , Greece
St. Luke s Hospital
Thessaloniki, , Greece
Tel Aviv Sourasky Medical Center
Tel Aviv, Other, Israel
Shaare Zedek Medical Center
Jerusalem, , Israel
Meir Medical Center
Kfar Saba, , Israel
Rabin Medical Center
Petah Tikva, , Israel
Kaplan Medical Center
Rehovot, , Israel
A.O.U. - Ospedali Riuniti di Ancona
Torrette (AN), Ancona, Italy
Azienda Ospedaliera di Rilievo Nazionale Sant'Anna e San Sebastiano
Caserta, Campania, Italy
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori- IRST S.r.l
Meldola, Emilia-Romagna, Italy
Policlinico Universitario Agostino Gemelli
Rome, Lazio, Italy
Ospedale San Raffaele
Milan, Lombardy, Italy
Fondazione IRCCS Istituto Nazionale Dei Tumori
Milan, Lombardy, Italy
U.O.C. Centro di Ricerca di Fase 1, Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy
U.O.C. Oncologia Medica, Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy
Centro di Riferimento Oncologico Di Aviano
Aviano, Pordenone, Italy
Azienda Ospedaliera Spedali Civili di brescia
Brescia, Province OF Brescia, Italy
Farmacia
Roma, ROME, Italy
Oncologia Medica 2
Roma, ROME, Italy
A.O.U Policlinico G. Rodolico S. Marco
Catania, Sicily, Italy
G Rodolico AOU Policlinico - S. Marco
Catania, , Italy
Clinica di Oncologia Medica Policlinico San Martino
Genova, , Italy
UOC Oncologia Medica - Azienda Ospedaliero - Universitaria di Parma
Parma, , Italy
Radiologia
Rome, , Italy
Aichi Cancer Center
Nagoya, Aichi-ken, Japan
National Cancer Center Hospital East
Kashiwa-shi, Chiba, Japan
NHO Shikoku Cancer Center
Matsuyama, Ehime, Japan
Kurume University Hospital
Kurume, Fukuoka, Japan
Gunma Prefectural Cancer Center
Ota-Shi, Gunma, Japan
Kobe City Hospital Organization Kobe City Medical Center General Hospital
Kobe, Hyōgo, Japan
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, Japan
Kanagawa Cancer Center
Yokohama, Kanagawa, Japan
Niigata Cancer Center Hospital
Niigata, Niigata, Japan
Kindai University Hospital
Sakai, Osaka, Japan
Osaka Medical and Pharmaceutical University Hospital
Takatsuki-shi, Osaka, Japan
Osaka International Cancer Institute
Osaka, Other, Japan
Shizuoka Cancer Center
Sunto-gun, Shizuoka, Japan
Nippon Medical School Hospital
Bunkyo-ku, Tokyo, Japan
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital
Bunkyo-ku, Tokyo, Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
The Cancer Institute Hospital of JFCR
Koto-ku, Tokyo, Japan
Martini Ziekenhuis
Groningen, , Netherlands
Maastricht UMC
Maastricht, , Netherlands
Erasmus Medisch Centrum Daniel Den Hoed
Rotterdam, , Netherlands
Vestre Viken Health Trust - Drammen Hospital
Drammen, , Norway
Vestre Viken Health Trust
Drammen, , Norway
Oslo University Hospital (OUH) - The Norwegian Radium Hospital
Oslo, , Norway
Sykehusapoteket Oslo, Radiumhospitalet - Avdeling Produksjon
Oslo, , Norway
Medical University of Gdansk
GdaDsk, Other, Poland
Instytut MSF Sp. z.o.o.
Lodz, , Poland
Institute of Genetics and Immunology GENIM LCC
Lublin, , Poland
Med-Polonia Sp. z.o.o.
Poznan, , Poland
S.C. Medisprof S.R.L
Cluj-Napoca, Cluj, Romania
Ovidius Clinical Hospital
Ovidiu, Constanța County, Romania
Institutul Oncologic "Prof. Dr. I. Chiricuta" Cluj-Napoca
Cluj-Napoca, Koblenz, Romania
SC Policlinica CCBR SRL
Bucharest, Sector 3, Romania
Memorial Healthcare International S.R.L
Bucharest, , Romania
Centrul de Oncologie Sf Nectarie
Craiova, , Romania
Ajou University Hospital.
Suwon, Gyeonggi-do, South Korea
St. Vincent's Hospital, The Catholic University of Korea.
Suwon, Gyeonggido [kyonggi-do], South Korea
Hospital Universitario Son Espases
Palma, Balearic Islands, Spain
CETIR Viladomat
Barcelona, Other, Spain
Hospital General Universitario Alicante
Alicante, Valencia, Spain
Complejo Hospitalario Universitario La Coruna
A Coruña, , Spain
Hospital General Universitario de Alicante - Farmacia
Alicante, , Spain
lnstitut Catala D'oncologia (ICO) Badalona - Hospital Universitari Germans Trias I Pujol
Badalona, , Spain
Hospital Universitari Vall d'Hebron
Barcelona, , Spain
Consorcio Hospitalario Provincial de Castellon
Castellon, , Spain
Hospital General Universitario Gregorio Maranon
Madrid, , Spain
Hospital Clinico San Carlos
Madrid, , Spain
Servicio de Farmacia Hospitalaria
Madrid, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Hospital Quironsalud Malaga
Málaga, , Spain
Fundación Instituto Valenciano de Oncología (FIVO)
Valencia, , Spain
Hospital Universitari i Politecnic La Fe
Valencia, , Spain
Hospital Clinico Universitario Lozano Blesa de Zaragoza
Zaragoza, , Spain
Kantonsspital Graubuenden
Chur, Graubünden (DE), Switzerland
Kantonsspital Graubünden/Medizinische Onkologie und Hämatologie
Chur, Graubünden (DE), Switzerland
Universitatsspital Basel
Basel, Other, Switzerland
Kantonsspital Graubuenden
Chur, Other, Switzerland
Universitatsspital Basel
Basel, , Switzerland
Inselspital
Bern, , Switzerland
University Hospital Lausanne CHUV
Lausanne, , Switzerland
Universitatsspital Zurich, Institut fur diagnostische und interventionelle Radiologie
Zurich, , Switzerland
Universitatsspital Zurich
Zurich, , Switzerland
Universitatsspital Zurich
Zurich, , Switzerland
National Taiwan University Hospital Yunlin Branch
Douliu, Yunlin, Taiwan
Changhua Christian Medical Foundation Changhua Christian Hospital
Changhua, , Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, , Taiwan
E-Da Hospital
Kaohsiung City, , Taiwan
Taipei Veterans General Hospital
Taipei, , Taiwan
Diagnostic Centre
London, Others, United Kingdom
The Harley Street Clinic (THSC)
London, Other, United Kingdom
The Royal Marsden NHS Foundation Trust (RM)
Sutton, Surrey, United Kingdom
The Beatson West of Scotland Cancer Centre
Glasgow, , United Kingdom
St. Bartholomew's Hospital - Barts Health NHS Trust
London, , United Kingdom
The Royal Marsden NHS Foundation Trust (RM).
London, , United Kingdom
The Royal Marsden NHS Foundation Trust (RM)
London, , United Kingdom
Sarah Cannon Research Institute UK
London, , United Kingdom
The Harley Street Clinic
London, , United Kingdom
The Harley Street Clinic
London, , United Kingdom
The Christie NHS Foundation Trust
Manchester, , United Kingdom
Royal Marsden Hospital Sutton
Sutton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C5751002
Identifier Type: OTHER
Identifier Source: secondary_id
2023-503827-25-01
Identifier Type: REGISTRY
Identifier Source: secondary_id
SGNB6A-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.